The short answer. Tesamorelin is the only FDA-approved compound here, and its approval is for a different indication entirely.
- CJC-1295 and ipamorelin have coherent mechanisms but thin human data behind them.
- Sermorelin has trials from the 1990s and was later discontinued as a drug.
- IGF-1 LR3 acts directly and carries the least safety data of the compounds on this list.
The list of peptides for muscle growth is shorter than the supplement aisle suggests. Nearly all of it comes from one hormone pathway, and the trials behind it were run to treat illness.
Rank the growth-hormone peptides by evidence, not by reputation. They line up like this. Tesamorelin is FDA-approved and has real trials. But those trials are for the wrong indication. CJC-1295 and ipamorelin have clear mechanisms. Their human data is thin. Sermorelin has 1990s trials. It was dropped as a drug. IGF-1 LR3 acts directly. It has the least safety data. Almost none were studied for muscle growth in healthy adults.
Nearly every “best peptides for muscle growth” list ranks by how often a compound is mentioned. This one ranks by what was actually measured. That produces a different and less exciting order. One framing note comes first. Raising growth hormone is a biochemical outcome. Building muscle is a clinical one. The literature is much stronger on the first than the second.
The ranking, by evidence
| Compound | Mechanism | Human evidence | The catch |
|---|---|---|---|
| Tesamorelin | Stabilized GHRH analog | Strongest here — FDA-approved as Egrifta | Approved for HIV lipodystrophy, not hypertrophy |
| CJC-1295 | GHRH analog; bigger GH pulses | Mechanistic, limited outcome data | DAC and no-DAC forms behave very differently |
| Ipamorelin | Selective GHS-R agonist; more frequent pulses | Mechanistic, limited outcome data | Selectivity is the selling point, not potency |
| Sermorelin | GHRH(1-29), the original fragment | 1990s trials restored IGF-1 to young-adult range | Discontinued as a drug; no modern RCTs |
| IGF-1 LR3 | Acts directly on muscle, bypassing the GH axis | Weakest human safety data of the group | Direct mitogenic action is exactly why that matters |
| Hexarelin | Most potent GH secretagogue of the class | Limited | Desensitizes fastest |
Why the GH axis dominates this list
Growth hormone drives IGF-1 production in the liver. IGF-1 is the anabolic signal that actually reaches muscle. Secretagogues do not give GH directly. They push the body's own pulsatile release. That is the argument for them. Pulsatility is how the axis normally works, and a continuous signal desensitizes it.
Two receptor routes exist. They are complementary, not redundant. GHRH analogs (sermorelin, CJC-1295, tesamorelin) increase pulse amplitude. Ghrelin-receptor agonists (ipamorelin, hexarelin) increase pulse frequency and suppress somatostatin. That non-overlap is the entire rationale for the CJC-1295 / ipamorelin stack. The GH axis overview covers the pharmacology properly.
The gap this list cannot close. Sermorelin's 1990s trials restored IGF-1 to the young-adult range in about two weeks. That is a real, measured, replicated biochemical effect. But no trial in this group went further. None established that the same step produces meaningful lean-mass gain in a healthy, trained adult who already eats and lifts enough. The mechanism is sound. The outcome study mostly does not exist. What the sermorelin trials actually showed is the clearest illustration.
The repair compounds, and why they're on stacks
BPC-157 and TB-500 turn up in almost every muscle-focused stack. They are not anabolic. The preclinical work is on tendon, ligament, muscle and gut healing. Their place in a training context is simple. Injuries stop training, and training is what builds muscle. That is an indirect route, and a legitimate one. It is a different claim from hypertrophy. See BPC-157 vs TB-500 and the Wolverine stack.
If you are buying any of these
The GH-axis compounds are among the most frequently underfilled and substituted in the market. There is a specific reason. They are dosed in micrograms. They are sold in small vials. And their effects are too subtle for a buyer to notice a shortfall. Nobody detects a 30% underfill of ipamorelin by feel.
That makes analytical verification the whole game here. A batch-matched certificate of analysis showing both HPLC purity and mass-spec identity is the floor — how to read one — and cost per mg is the only fair way to compare across the vial sizes these are sold in. Per-compound sourcing guides: ipamorelin, CJC-1295, tesamorelin.
Which vendors publish a certificate you can check?
Eight of the ten retailers below publish a real third-party certificate. Only three name the testing lab in their own site copy; the rest make you open the PDF to find out who ran the assay. That gap is the one worth pricing, because a lab named on the page is a claim the vendor has to stand behind in public.
Checked against each storefront on 2026-08-13. Disclosure: Where To Buy Peptides earns a commission on purchases made through its links.
| Vendor | Third-party COA | Testing lab | Where the lab is named | Ships free at |
|---|---|---|---|---|
| Sports Technology Labs | Published | MZ Biolabs + Colmaric | Site and document | $149 |
| Swiss Chems | Published | Janoshik | Site (FAQ) | $100 |
| Core Peptides | Published (A2LA #6377.01.01) | Vanguard Laboratory | Document only | $200 |
| PS Peptides | Published | North American Diagnostics | Document only | $200 |
| BioTech Peptides | Published | MZ Biolabs | Document only | $200 |
| American Peptides | Published, with lot lookup | Bioviridian Inc. | Document only | $300 |
| Limitless Biotech | On Google Drive | Janoshik, named on the document | Neither | None |
| Behemoth Labz | Published but around two years stale | MZ Biolabs / Colmaric | Document only | $100 |
| Red Rock Peptides | Claims only, none published | None named | Neither | Not offered |
Existence is the easy test, and it is not the useful one. Coverage and freshness are where these come apart: Swiss Chems holds 47 reports for around 142 products, Behemoth's newest genuine certificate is dated 2024-08-08, Core Peptides and BioTech Peptides both have SKUs with none at all, and Red Rock publishes nothing while advertising “Verified With COAs”. Ask for the certificate that matches the lot number on your vial, not a specimen one.
Frequently asked questions
What are the best peptides for muscle growth?
The honest ranking is by evidence quality, not by reputation. Tesamorelin has the strongest data because it is FDA-approved as Egrifta with real trials behind it, though for HIV-associated lipodystrophy rather than muscle building. CJC-1295 and ipamorelin have coherent mechanisms and thin human evidence. IGF-1 LR3 acts directly on muscle and has the least human safety data of the group.
Do growth hormone peptides actually build muscle?
They raise growth hormone and IGF-1, which is not the same claim. Restoring an IGF-1 level to the young-adult range is a measurable biochemical change; producing meaningful hypertrophy in a healthy trained adult is a clinical outcome, and almost no trial in this space measured the second one.
What is the difference between CJC-1295 and ipamorelin?
They act on different receptors and are usually discussed together for that reason. CJC-1295 is a GHRH analog that increases the size of GH pulses; ipamorelin is a selective ghrelin-receptor agonist that increases their frequency. The rationale for stacking them is complementary mechanism, not additive dosing.
Is BPC-157 a muscle-building peptide?
No. BPC-157 is a tissue-repair compound — the preclinical work is on tendon, muscle, ligament and gut healing, not hypertrophy. It appears in muscle-focused stacks because training injuries interrupt training, which is a different mechanism of benefit entirely.
What to know now
- Tesamorelin is the only FDA-approved compound here, and its approval is for a different indication entirely.
- CJC-1295 and ipamorelin have coherent mechanisms but thin human data behind them.
- Sermorelin has trials from the 1990s and was later discontinued as a drug.
- IGF-1 LR3 acts directly and carries the least safety data of the compounds on this list.
- Almost none of these were studied for muscle growth in healthy adults, which is the gap everything else sits on.
References
- Raun, K., Hansen, B. S., Johansen, N. L., et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552–561. https://doi.org/10.1530/eje.0.1390552
- Sigalos, J. T., & Pastuszak, A. W. (2018). The safety and efficacy of growth hormone secretagogues. Sexual Medicine Reviews, 6(1), 45–53. https://doi.org/10.1016/j.sxmr.2017.02.004
- Falutz, J., Allas, S., Mamputu, J. C., et al. (2008). Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation. AIDS, 22(14), 1719–1728. https://doi.org/10.1097/qad.0b013e32830a5058
- Vasireddi, N., Hahamyan, H., Salata, M. J., et al. (2025). Emerging use of BPC-157 in orthopaedic sports medicine: A systematic review. HSS Journal, 21(4). https://doi.org/10.1177/15563316251355551
Tesamorelin's evidence is from its HIV-lipodystrophy programme, which is the indication it is approved for — not hypertrophy.